TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34226496

Group type: EXPERIMENTAL
Intervention: Psychotropic medications associated with weight gain
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Psychotropic medications with high risk of weight gain
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Educational attainment (EA) as a proxy for SES
Number of subjects: 366
Study: 32618247

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-Piperaquine (DHAP) administered in four rounds of mass drug administration (MDA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care without any mass treatment
Number of subjects: 0
Study: 35882260

Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 187

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 187
Study: 32112077

Group type: EXPERIMENTAL
Intervention: Randomization-based confidence intervals using individual-level data from a CRT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization test for obtaining confidence intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed method for randomization-based CIs
Number of subjects: 0
Study: 32891607

Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (PSD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal sleep night (CONT)
Number of subjects: 20
Study: 35338833

Group type: EXPERIMENTAL
Intervention: Involvement of relatives during home visits by a geriatric team
Number of subjects: 437

Group type: COMPARATOR
Intervention: No involvement of relatives during home visits by a geriatric team
Number of subjects: 437
Study: 34405423

Group type: EXPERIMENTAL
Intervention: MultiPole Pacing (MPP) therapy
Number of subjects: 53
Study: 34175944

Group type: EXPERIMENTAL
Intervention: Standing orders for syphilis serological testing with viral loads
Number of subjects: 3895

Group type: COMPARATOR
Intervention: Usual practice (control)
Number of subjects: 3895
Study: 33095965

Group type: EXPERIMENTAL
Intervention: EJV-based landmark (EJV-LM) approach
Number of subjects: 188

Group type: COMPARATOR
Intervention: Ultrasound (US)-guided approach
Number of subjects: 188
Study: 32215583

Group type: EXPERIMENTAL
Intervention: SRT plus high-dose nonsteroidal antiandrogen (bicalutamide, 150 mg/d) for 2 years
Number of subjects: 760

Group type: COMPARATOR
Intervention: SRT plus placebo for 2 years
Number of subjects: 760
Study: 35291282

Group type: EXPERIMENTAL
Intervention: CoQ10 with MAG-OM3
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CoQ10 with rice oil
Number of subjects: 30

Group type: COMPARATOR
Intervention: CoQ10 alone
Number of subjects: 30
Study: 34011271

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA) at baseline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 0
Study: 32315070

Group type: EXPERIMENTAL
Intervention: At least 2 pivotal trials
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Single-group pivotal trials
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Pivotal trials of 6 months' duration
Number of subjects: 273
Study: 36329722

Group type: EXPERIMENTAL
Intervention: Aframomum melegueta seed extract (AfperFit) 250 mg, twice daily for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 32533332

Group type: EXPERIMENTAL
Intervention: Femoral triangle block (FT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Adductor canal block (AC)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Functional mobility (TUG test)
Number of subjects: 98
Study: 35831693

Group type: EXPERIMENTAL
Intervention: Parent Training (PT) intervention (n = 60)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Psychoeducational toolkit (n = 59)
Number of subjects: 119
Study: 34468709

Group type: EXPERIMENTAL
Intervention: Complex PCI
Number of subjects: 3377

Group type: COMPARATOR
Intervention: Non-complex PCI
Number of subjects: 3377
Study: 33037808

Group type: EXPERIMENTAL
Intervention: Xylitol–malic acid tablets (as a supplement to omeprazole 40 mg/day)
Number of subjects: 14
Study: 35118156

Group type: EXPERIMENTAL
Intervention: Autologous adipose-derived stromal vascular fractions (SVF) injections
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injections
Number of subjects: 0
Study: 34001168

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic supplementation (E, n=11)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo group (C, n=16)
Number of subjects: 27
Study: 34332547

Group type: EXPERIMENTAL
Intervention: Cerebral oxygenation monitoring treatment
Number of subjects: 818

Group type: COMPARATOR
Intervention: Monitoring and treatment as usual
Number of subjects: 818
Study: 32472875

Group type: EXPERIMENTAL
Intervention: Immediate addition of nasal stent
Number of subjects: 20

Group type: COMPARATOR
Intervention: Delayed addition of nasal stent
Number of subjects: 20
Study: 33876259

Group type: EXPERIMENTAL
Intervention: Ibuprofen before exercise (IP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo before and ibuprofen after exercise (PI)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo before and after exercise (PP)
Number of subjects: 42
Study: 32545223

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with toluidine blue O and LED light, applied at baseline and 3-months in addition to non-surgical periodontal treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-surgical periodontal treatment
Number of subjects: 36
Study: 35450527

Group type: EXPERIMENTAL
Intervention: Ultramicronized PEA-LUT 770 mg plus olfactory training
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo plus olfactory training
Number of subjects: 185
Study: 34800400

Group type: EXPERIMENTAL
Intervention: Cipaglucosidase alfa plus miglustat
Number of subjects: 125

Group type: COMPARATOR
Intervention: Alglucosidase alfa plus placebo
Number of subjects: 125
Study: 32571859

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme (12-week tailored programme with weekly telephone calls for exercise progression)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35546694

Group type: EXPERIMENTAL
Intervention: Gelatine-based model training (Group 1: n: 26)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No model training (Group 2: n: 22)
Number of subjects: 48
Study: 33839477

Group type: EXPERIMENTAL
Intervention: Spanish version of the ASQ‐3 (18‐ to 54‐month questionnaires)
Number of subjects: 4016

Group type: EXPERIMENTAL
Intervention: Spanish version of the ASQ‐3
Number of subjects: 4016
Study: 35091136

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 236

Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 236
Study: 34127645

Group type: EXPERIMENTAL
Intervention: Jackfruit365™ green jackfruit flour 30 g/day (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo flour (Group B)
Number of subjects: 40
Study: 33451962

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (20 mg bolus followed by 5 μg/kg/min infusion)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Narcotic-only control (100 μg fentanyl with additional fentanyl and 0.3 mg hydromorphone)
Number of subjects: 54
Study: 36316835

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 81

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both Sevoflurane and Desflurane
Number of subjects: 81
Study: 35197374

Group type: EXPERIMENTAL
Intervention: NanoCare Gold
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control
Number of subjects: 19
Study: 32160948

Group type: EXPERIMENTAL
Intervention: RV3-BB rotavirus vaccine (neonatal schedule, first dose at 0-5 days of age)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: RV3-BB rotavirus vaccine (infant schedule, first dose at 8 weeks of age)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 34187468

Group type: EXPERIMENTAL
Intervention: Phone-based recruitment
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: In-person recruitment
Number of subjects: 1068

Group type: EXPERIMENTAL
Intervention: Overall recruitment strategies
Number of subjects: 1068
Study: 36056407

Group type: EXPERIMENTAL
Intervention: PEER intervention added to service as usual (SAU)
Number of subjects: 284

Group type: COMPARATOR
Intervention: SAU alone
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: PEER intervention added to SAU
Number of subjects: 284
Study: 32770394

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cancer Recovery (MBCR)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 77
Study: 35657651

Group type: EXPERIMENTAL
Intervention: OROS-methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33357606

Group type: EXPERIMENTAL
Intervention: MedMinder 'Jon' electronic pillbox
Number of subjects: 25

Group type: COMPARATOR
Intervention: Treatment-as-usual (control condition)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pillbox alerts
Number of subjects: 25
Study: 32739537

Group type: EXPERIMENTAL
Intervention: Immediate complete revascularization (experimental arm)
Number of subjects: 1525

Group type: COMPARATOR
Intervention: Culprit-only plus staged complete revascularization (control arm)
Number of subjects: 1525
Study: 33735670

Group type: EXPERIMENTAL
Intervention: Inhaled levosimendan (LS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous levosimendan (LS)
Number of subjects: 50
Study: 32569102

Group type: EXPERIMENTAL
Intervention: Daily 30-minute massage for 7 consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Daily 30-minute restriction of non-essential caregiving (Quiet Time) for 7 consecutive days
Number of subjects: 60
Study: 33450972

Group type: EXPERIMENTAL
Intervention: Post-operative compression stockings and individualized exercise education (Intervention Group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Education on lymphedema risk-reduction alone (Control Group)
Number of subjects: 51
Study: 33006562

Group type: EXPERIMENTAL
Intervention: Two-way SMS text messaging
Number of subjects: 232

Group type: COMPARATOR
Intervention: One-way SMS text messaging
Number of subjects: 232
Study: 34973853

Group type: EXPERIMENTAL
Intervention: burn+glutamine (B+G)
Number of subjects: 55

Group type: COMPARATOR
Intervention: burn control (B)
Number of subjects: 55
Study: 34187394

Group type: EXPERIMENTAL
Intervention: Nifedipine/indomethacin combination therapy
Number of subjects: 117

Group type: COMPARATOR
Intervention: Nifedipine monotherapy
Number of subjects: 117
Study: 33527395

Group type: EXPERIMENTAL
Intervention: Eperisone 50 mg (Murex®)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Population PK modeling
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Covariate analysis
Number of subjects: 15
Study: 33218498

Group type: EXPERIMENTAL
Intervention: Positive verbal input (n=25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Negative verbal input (n=25)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 75
Study: 616886746

Group type: EXPERIMENTAL
Intervention: Chinese medicine-based nursing care
Number of subjects: 95
Study: 34306274

Group type: EXPERIMENTAL
Intervention: Multidimensional treatment (MT) group, n = 30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unimodal treatment (UT) group, n = 30
Number of subjects: 60
Study: 35352373

Group type: EXPERIMENTAL
Intervention: Gluten (10 g in two granola bars for 7 days)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (two granola bars without gluten for 7 days)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Gluten
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 34292562

Group type: EXPERIMENTAL
Intervention: Protamine sulfate (PS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 100
Study: 32244279

Group type: EXPERIMENTAL
Intervention: Multivitamins (containing 50 µg vitamin B12)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491
Study: 34678466

Group type: EXPERIMENTAL
Intervention: iDBT-Pain intervention (four weeks of online DBT skills training with one-on-one sessions over Zoom and a web app)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: iDBT-Pain intervention
Number of subjects: 3
Study: 33971824

Group type: EXPERIMENTAL
Intervention: Second forward-view examination (SFE)
Number of subjects: 392
Study: 32650886

Group type: EXPERIMENTAL
Intervention: Educational pain management program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 200
Study: 35763357

Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 mcg/kg/min from anesthetic induction
Number of subjects: 19

Group type: COMPARATOR
Intervention: Milrinone 0.5 mcg/kg/min (control)
Number of subjects: 19
Study: 34417064

Group type: EXPERIMENTAL
Intervention: Graphic narrative informed consent
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard informed consent
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study: 32710888

Group type: EXPERIMENTAL
Intervention: Ramadan intermittent fasting (RIF) for 30 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CG) with normal daily habits
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Experimental group (EG) after RIF
Number of subjects: 28
Study: 34704121

Group type: EXPERIMENTAL
Intervention: Safflower oil (SAF)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Palm oil (PAL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle (VCL)
Number of subjects: 16
Study: 34649590

Group type: EXPERIMENTAL
Intervention: 10 weekly sessions of virtually delivered qualified exercise professional (QEP) support
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group without QEP support
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 10 weekly sessions of virtually delivered QEP support
Number of subjects: 108
Study: 35604689

Group type: EXPERIMENTAL
Intervention: Standard‐plus (timing and coordination training)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Standard strength and endurance training
Number of subjects: 249
Study: 34659642

Group type: EXPERIMENTAL
Intervention: Systematic oxidative stress score (SOS) based on five biomarkers: serum creatinine (CRE), serum albumin (ALB), total bilirubin (TBIL), lactate dehydrogenase (LDH), and blood urea nitrogen (BUN)
Number of subjects: 1583

Group type: EXPERIMENTAL
Intervention: Nomogram based on SOS and clinical characteristics
Number of subjects: 1583
Study: 36781628

Group type: EXPERIMENTAL
Intervention: Discrete Choice Experiment
Number of subjects: 140

Group type: COMPARATOR
Intervention: BWS-2
Number of subjects: 140
Study: 34275240

Group type: EXPERIMENTAL
Intervention: Video distraction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 34776340

Group type: EXPERIMENTAL
Intervention: Dietary fiber intake
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Healthy plant-based diet index
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Higher protein-to-fiber ratio
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intake of vegetables and whole grains
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Unclassified Prevotella species
Number of subjects: 68
Study: 32458093

Group type: EXPERIMENTAL
Intervention: Enhanced super-mini-PCNL (eSMP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional Chinese mini‐PCNL (mPCNL)
Number of subjects: 100
Study: 35253730

Group type: EXPERIMENTAL
Intervention: TENS (frequency 100 Hz, burst-rate 2 Hz, burst-width 150 μs, intensity 40 mA, duration 30 min)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham-TENS
Number of subjects: 62
Study: 33151934

Group type: EXPERIMENTAL
Intervention: Brief Support (BS)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Brief Support + Shopping Feedback (SF)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control
Number of subjects: 113
Study: 36383848

Group type: EXPERIMENTAL
Intervention: Happy Child Program (PCF)
Number of subjects: 3242

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 3242
Study: 32291982

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 1.0 g TXA before operation (Group B)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 1.0 g TXA before operation combined with local use of TXA cocktail during operation (Group C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No TXA administered (Group A)
Number of subjects: 45
Study: 36201815

Group type: EXPERIMENTAL
Intervention: Dialogic reading with parents (PR-DR)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Dialogic reading with siblings (SR-DR)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Parent reading control (PR-C)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Sibling reading control (SR-C)
Number of subjects: 850
Study: 33159536

Group type: EXPERIMENTAL
Intervention: Air pyelogram
Number of subjects: 122

Group type: COMPARATOR
Intervention: Contrast pyelogram
Number of subjects: 122
Study: 35436844

Group type: EXPERIMENTAL
Intervention: CTB group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 33653410

Group type: EXPERIMENTAL
Intervention: Emotion regulation training (eight 90-min sessions, one session weekly)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 36088189

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 175

Group type: COMPARATOR
Intervention: HF self-care education
Number of subjects: 175
Study: 34670026

Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) of the ventral capsule/ventral striatum (VC/VS)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Number of subjects: 8
Study: 36457115

Group type: EXPERIMENTAL
Intervention: Prophylactic surgery plus hybrid CO2 HIPEC system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard surgery
Number of subjects: 0
Study: 34288699

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE plus radiosensitizing capecitabine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Octreotide long-acting release (LAR)
Number of subjects: 76
Study: 35377998

Group type: EXPERIMENTAL
Intervention: Probiotic mouthwash
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32591421

Group type: EXPERIMENTAL
Intervention: Fructose (20 g) intake 30 minutes prior to exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no fructose intake)
Number of subjects: 14
Study: 70706386

Group type: EXPERIMENTAL
Intervention: Early debridement of one side of the nose postoperatively.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control side (no debridement).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Debridement (removal of crusting).
Number of subjects: 0
Study: 36498598

Group type: EXPERIMENTAL
Intervention: Conventional stented group (CSG)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nonstented group (NSG)
Number of subjects: 104
Study: 33160147

Group type: EXPERIMENTAL
Intervention: Tamoxifen with reported hot flushes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen with reported hot flushes in postmenopausal women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen with gynaecological side effects
Number of subjects: 0
Study: 35469517

Group type: EXPERIMENTAL
Intervention: Standard care plus the ISP team (intervention group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 58
Study: 34911175

Group type: EXPERIMENTAL
Intervention: Delphi technique for ASA classification
Number of subjects: 37
Study: 35522900

Group type: EXPERIMENTAL
Intervention: ATx201 OINTMENT 2%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 36
Study: 32281943

Group type: EXPERIMENTAL
Intervention: Nutritionist Buddy (nBuddy) mobile app + dietary and lifestyle advice by a dietitian
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard care (dietary and lifestyle advice by a trained nurse)
Number of subjects: 108
Study: 32605633

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 0
Study: 33290097

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training applications (CCTA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo-control group
Number of subjects: 32
Study: 33393175

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT) injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33830090

Group type: EXPERIMENTAL
Intervention: Self-reported flare (SRF)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Greater than average pain (PDF)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: SRF+PDF
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Self-efficacy at work and during leisure activities
Number of subjects: 126
Study: 32141095

Group type: EXPERIMENTAL
Intervention: Corrected estimator of sensitive population proportion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Greenberg et al.'s estimator
Number of subjects: 0
Study: 32699918

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control
Number of subjects: 52
Study: 33317621

Group type: EXPERIMENTAL
Intervention: MSI-195 (400, 800, and 1600 mg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: MSI-195
Number of subjects: 34

Group type: COMPARATOR
Intervention: SAM-e Complete™
Number of subjects: 34
Study: 36455422

Group type: EXPERIMENTAL
Intervention: Dyspnea Challenge in HF
Number of subjects: 46

Group type: COMPARATOR
Intervention: Dyspnea Challenge in COPD
Number of subjects: 46
Study: 34403486

Group type: EXPERIMENTAL
Intervention: Chlorhexidine cloths
Number of subjects: 0
Study: 37013278

Group type: EXPERIMENTAL
Intervention: Tramadol 1mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 80
Study: 33505516

Group type: EXPERIMENTAL
Intervention: iT3SE-PX method using protein sequences and features from PSSM profiles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extreme gradient boosting (XGBoost) algorithm for feature ranking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Support vector machine (SVM) classifier for prediction
Number of subjects: 0